$ANL

$10.58 +$0.00 (0.0%) Close

$ANL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 210.2M shares outstanding

Who owns ANL?

By type of holder

Institutions 12.5% Insiders 0.0% Everyone else 87.5%

Concentration Top 10 holders own 9.5%

Cormorant Asset Management, LP 1.9% · Venrock Adviser, LLC 1.5%

Institutional ownership

12.5%

+7.0 pts vs last qtr

Institutional holders

+15 vs last qtr

Net shares bought

+14.6M

by institutions in Q2 2026

New / sold out

21 / 6

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Balyasny Asset Management L.P. +2.2M
Point72 Asset Management, L.P. NEW +2.1M

Biggest sellers in Q2 2026

Squadron Capital Management LLC −500.4K
Price T Rowe Associates Inc /MD/ SOLD OUT −99.8K

Who is planning to sell?

Notices of proposed sale, last 12 months

$1.22M

1 notice from 1 person

Shares covered

80.0K

0.04% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Ji Ping Director $1.22M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Adlai Nortye Group Ltd.

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

70.7%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting ANL on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CA Cormorant Asset Management, LP	4.0M	1.89%	+1.1M (+37.3%)	Q1 '26	2.3%
Shares held by quarter Peak holding4.0M (Q2'26) Change over 8 quarters+4.0M Share of the company1.890% Cormorant Asset Management, LP's full portfolio →
VA Venrock Adviser, LLC	3.2M	1.53%	Unchanged	Q1 '26	1.1%
Shares held by quarter Peak holding3.2M (Q1'26) Change over 8 quarters+3.2M Share of the company1.530% Venrock Adviser, LLC's full portfolio →

Cormorant Asset Management, LP

4.0M

% of company

1.89%

Change vs last qtr

+1.1M (+37.3%)

Held since

Q1 '26

Venrock Adviser, LLC

3.2M

% of company

1.53%

Change vs last qtr

Unchanged

Held since

Q1 '26

28 more super investors behind a free account

See every manager holding Adlai Nortye Group Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting ANL on Form N-PORT; together they hold 0.5% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
EH Eventide Healthcare & Life Sciences Fund Mutual Fund Series Trust	$8.27M	718.7K	0.34%	0.46%	June 30, 2026
TR T. Rowe Price Health Sciences Fund, Inc. T. Rowe Price Health Sciences Fund, Inc.	$1.52M	219.7K	0.10%	0.01%	March 31, 2026

Eventide Healthcare & Life Sciences Fund

Mutual Fund Series Trust

Position value

$8.27M

% of company

0.34%

% of the fund

0.46%

As of

June 30, 2026

T. Rowe Price Health Sciences Fund, Inc.

Position value

$1.52M

% of company

0.10%

% of the fund

0.01%

As of

March 31, 2026

8 more funds behind a free account

See every fund holding Adlai Nortye Group Ltd and how much of the fund the position is.

Comments